Design of Telomerase Inhibitors for the Treatment of Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|8|27|2491-2504

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.27, 2002-12, pp. : 2491-2504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telomerase inhibitors for the treatment of cancer: the current perspective

By Perry Philip J   Arnold John RP   Jenkins Terence C  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 12, 2001-12 ,pp. : 2141-2156

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in the development of telomerase inhibitors for the treatment of cancer

By Perry P.J.   Jenkins T.C.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 1981-2008

Informa Healthcare

Access to resources Recommend Favorite

The Design of G-quadruplex Ligands as Telomerase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 1, 2003-02 ,pp. : 11-21

Bentham Science Publishers

Access to resources Recommend Favorite

Telomerase as Drug and Drug Target for the Treatment of Thyroid Cancer

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 3, 2004-09 ,pp. : 253-256

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis inhibitors in the treatment of cancer

By Rhee Jay   Hoff Paulo M  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1701-1711

Informa Healthcare

Access to resources Recommend Favorite